Trees (CANN) 10-Q 22 May 23 2023 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 22, 2023
Document And Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	000-54457
Entity Registrant Name	TREES CORPORATION
Entity Incorporation, State or Country Code	CO
Entity Tax Identification Number	90-1072649
Entity Address, Address Line One	215 Union Boulevard
Entity Address, Address Line Two	Suite 415
Entity Address, City or Town	Lakewood
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80228
City Area Code	303
Local Phone Number	759-1300
Title of 12(b) Security	N/A
Security Exchange Name	NONE
No Trading Symbol Flag	true
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		118,664,094
Entity Central Index Key	0001477009
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 1,460,162	$ 2,583,833
Accounts receivable, net of allowance of $42,000, respectively	62,841	41,373
Inventories	2,413,115	2,066,662
Prepaid expenses and other current assets	262,633	259,598
Total current assets	4,198,751	4,951,466
Right-of-use operating lease asset	4,029,769	3,866,406
Property and equipment, net	1,888,239	1,947,969
Intangible assets, net	2,925,631	2,543,898
Goodwill	18,384,974	18,384,974
Total assets	31,427,364	31,694,713
Current liabilities
Accounts payable and accrued expenses	2,627,318	1,899,450
Interest payable	909,699	488,813
Income tax payable	290,659	204,917
Operating lease liability, current	843,431	1,433,184
Finance lease liability, current	60,008	55,777
Accrued stock payable	60,900	60,900
Accrued dividends	106,200	88,500
Warrant derivative liability	4,201	5,508
Notes payable - current	1,879,173	1,903,344
Total current liabilities	6,781,589	6,140,393
Operating lease liability, non-current	3,314,127	2,541,590
Finance lease liability, non-current	689,497	706,653
Notes payable - non-current (net of unamortized discount)	16,112,500	15,899,588
Total liabilities	26,897,713	25,288,224
Commitments and contingencies (Note 10)
Stockholders' equity
Preferred stock, no par value; 5,000,000 shares authorized; 1,180 issued and outstanding, respectively	1,073,446	1,073,446
Common stock, $0.001 par value; 200,000,000 shares authorized; 118,664,094 shares issued and outstanding, respectively	118,664	118,664
Additional paid-in capital	98,626,157	98,598,761
Accumulated deficit	(95,288,616)	(93,384,382)
Total stockholders' equity	4,529,651	6,406,489
Total liabilities and stockholders' equity	$ 31,427,364	$ 31,694,713

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts receivable, net of allowance	$ 42,000	$ 42,000
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	1,180	1,180
Preferred stock, shares outstanding	1,180	1,180
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	118,664,094	118,664,094
Common stock, shares outstanding	118,664,094	118,664,094

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenue	$ 5,110,619	$ 3,573,308
Costs and expenses
Cost of sales	3,057,714	2,074,888
Selling, general and administrative	2,296,240	1,326,116
Stock-based compensation	27,396	76,117
Professional fees	607,544	281,384
Depreciation and amortization	292,842	231,846
Total costs and expenses	6,281,736	3,990,351
Operating loss	(1,171,117)	(417,043)
Other expenses (income)
Amortization of debt discount	181,677	214,281
Interest expense	449,311	174,351
(Gain) loss on derivative liability	(1,307)	60,664
Total other expenses, net	629,681	449,296
Net loss from continuing operations before income taxes	(1,800,798)	(866,339)
Provision for income taxes	85,736
Loss from continuing operations	(1,886,534)	(866,339)
Income from discontinued operations, net of tax		5,283
Net loss	(1,886,534)	(861,056)
Accrued preferred stock dividend	(17,700)
Net loss attributable to common stockholders	$ (1,904,234)	$ (861,056)
Per share data - basic and diluted
Net loss from continuing operations basic per share	$ (0.02)	$ (0.01)
Net loss from continuing operations diluted per share	(0.02)	(0.01)
Net loss from discontinued operations basic per share	0	0
Net loss from discontinued operations diluted per share	0	0
Net loss attributable to common stockholders basic per share	(0.02)	(0.01)
Net loss attributable to common stockholders diluted per share	$ (0.02)	$ (0.01)
Weighted average number of common shares outstanding, basic	118,664,094	95,749,505
Weighted average number of common shares outstanding, diluted	97,166,607	95,749,505
Retail sales
Total revenue	$ 5,110,619	$ 3,297,546
Cultivation sales
Total revenue		$ 275,762

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (1,886,534)	$ (861,056)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Amortization of debt discount and equity issuance costs	181,677	214,281
Depreciation and amortization	292,842	231,846
Non-cash lease expense	19,421	298,484
Bad debt expense		(5,085)
(Gain) loss on derivative liability	(1,307)	60,664
Stock-based compensation	27,396	76,117
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	(21,468)	13,892
Prepaid expenses and other assets	(3,035)	(17,142)
Inventories	(346,453)	(59,278)
Income taxes	85,742
Accounts payable, accrued liabilities, and interest payable	1,148,754	370,074
Operating lease liabilities		(277,574)
Net cash (used in) provided by operating activities:	(502,965)	45,223
Cash flows from investing activities
Purchase of property and equipment	(24,310)	(8,571)
Proceeds on notes receivable		75,000
Net cash used in investing activities	(280,892)	(190,153)
Cash flows from financing activities
Payments on notes payable and finance lease	(339,814)	(258,057)
Net cash used in financing activities	(339,814)	(258,057)
Net decrease in cash and cash equivalents	(1,123,671)	(402,987)
Cash and cash equivalents, beginning of period	2,583,833	2,054,050
Cash and cash equivalents, end of period	1,460,162	1,651,063
Supplemental schedule of cash flow information
Cash paid for interest	28,425	1,851
Cash paid for taxes	6
Non-cash investing & financing activities
Non-cash debt issuance for acquisition of Station 2 assets	333,953
Issuance of accrued stock	17,700	383,994
Station 2 Assets Acquisition
Cash flows from investing activities
Acquisition	$ (256,582)
TREES MLK
Cash flows from investing activities
Acquisition		$ (256,582)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock	Common Stock Trees Waterfront LLC	Common Stock Trees MLK LLC	Common Stock	Additional Paid-in Capital Trees Waterfront LLC	Additional Paid-in Capital Trees MLK LLC	Additional Paid-in Capital	Accumulated Deficit	Trees Waterfront LLC	Trees MLK LLC	Total
Balance at the beginning of the year at Dec. 31, 2021	$ 1,073,446			$ 89,550			$ 92,265,392	$ (83,820,815)			$ 9,607,573
Balance at the beginning of the year (in Shares) at Dec. 31, 2021	1,180			89,551,993
Common stock issued for acquisition		$ 1,670	$ 4,971		$ 382,324	$ 1,337,105			$ 383,994	$ 1,342,076
Common stock issued for acquisition (in shares)		1,669,537	4,970,654
Stock-based compensation							76,117				76,117
Net loss								(861,056)			(861,056)
Balance at the end of the year at Mar. 31, 2022	$ 1,073,446			$ 96,191			94,060,938	(84,681,871)			10,548,704
Balance at the end of the year(in Shares) at Mar. 31, 2022	1,180			96,192,184
Balance at the beginning of the year at Dec. 31, 2022	$ 1,073,446			$ 118,664			98,598,761	(93,384,382)			6,406,489
Balance at the beginning of the year (in Shares) at Dec. 31, 2022	1,180			118,664,094
Stock-based compensation							27,396				27,396
Dividends on preferred stock								(17,700)			(17,700)
Net loss								(1,886,534)			(1,886,534)
Balance at the end of the year at Mar. 31, 2023	$ 1,073,446			$ 118,664			$ 98,626,157	$ (95,288,616)			$ 4,529,651
Balance at the end of the year(in Shares) at Mar. 31, 2023	1,180			118,664,094

NATURE OF OPERATIONS, HISTORY A

NATURE OF OPERATIONS, HISTORY AND PRESENTATION	3 Months Ended
	Mar. 31, 2023
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
NATURE OF OPERATIONS, HISTORY AND PRESENTATION	NOTE 1. NATURE OF OPERATIONS, HISTORY, AND PRESENTATION Nature of Operations TREES Corporation, a Colorado Corporation (the “Company,” “we,” “us,” or “our,”) is a cannabis retailer and cultivator in the States of Colorado and Oregon. We presently operate eight (8) cannabis dispensaries as follows: ● Englewood, Colorado o 5005 S. Federal Boulevard – Recreational license only ● Two (2) in Denver, Colorado o 468 S. Federal Boulevard – Recreational license only o East Hampden Avenue (formerly Green Man) – Recreational license only ● Longmont, Colorado o 12626 N. 107 th Street (formerly Green Tree/Ancient Alternatives) – Medical and Recreational licenses ● Berthoud, Colorado o 1090 N. 2 nd Street (formerly Green Tree/Natural Alternatives for Life) – Medical and Recreational licenses ● Three (3) in Oregon o SW Corbett Avenue, Portland, OR – Medical and Recreational licenses o NE 102 nd Avenue, Portland, OR – Medical and Recreational licenses o 7050 NE MLK, Portland, OR – Medical and Recreational licenses ​ ​ We also operate five (5) cultivation facilities in Colorado as follows: ● SevenFive Farm – 3705 N. 75 th Street, Boulder – Retail cultivation license only ● 6859 N. Foothills Highway D-300 (formerly Green Tree/Ancient Alternatives) – Medical and Retail cultivation licenses ● 6859 N. Foothills Highway C-100 (formerly Green Tree/Mountainside Industries) – Medical and Retail cultivation licenses ● 6859 N. Foothills Highway E-100 (formerly Green Tree/Hillside Enterprises) – Retail cultivation license only ● 1090 N. 2 nd Street (formerly Green Tree/Natural Alternatives for Life) – Medical cultivation license only ​ Our principal business model is to acquire, integrate and optimize cannabis companies in the retail and cultivation segments utilizing the combined experience of entrepreneurs and synergistic operations of our vertically integrated network. Discontinued Operations - Operations Consulting and Products (“Operations Segment”) Through Next Big Crop (“NBC”), we delivered comprehensive consulting services to the cannabis industry that included obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and construction, and expansion of existing operations. ​ NBC oversaw our wholesale equipment and supply business, operating under the name “GC Supply,” which provided turnkey sourcing and stocking services to cultivation, retail, and infused products manufacturing facilities. Our products included building materials, equipment, consumables, and compliance packaging. NBC also provided operational support for our internal cultivation. On July 16, 2021, we entered into an Asset Purchase Agreement with an individual to sell substantially all the assets of NBC for a total of $150,000 and 10% of profits generated by the buyer in the states of Michigan, Mississippi, and Massachusetts for a period of twelve months from the closing. On August 2, 2021, the sale of NBC was completed. Pursuant to amendment, the buyer paid the additional Basis of Presentation The accompanying unaudited condensed consolidated financial statements include all accounts of the Company and its wholly owned subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. These unaudited condensed consolidated financial statements have been prepared following the requirements of the Securities and Exchange Commission for interim reporting. As permitted under those rules, certain footnotes and other financial information that are normally required by accounting principles generally accepted in the United States of America ("U.S. GAAP") can be condensed or omitted. The condensed consolidated balance sheet for the year ended December 31, 2022, was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The information included in this quarterly report on Form 10-Q should be read in conjunction with the audited consolidated financial statements and notes thereto of the Company for the year ended December 31, 2022, which were included in the annual report on Form 10-K filed by the Company on April 17, 2023. In the opinion of management, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and notes thereto of the Company and include all adjustments, consisting only of normal recurring adjustments, considered necessary for the fair presentation of the Company's financial position and operating results. The results for the three months ended March 31, 2023, are not necessarily indicative of the operating results for the year ending December 31, 2023, or any other interim or future periods. Since the date of the Annual Report, there have been no material changes to the Company’s significant accounting policies. Reclassifications Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. Use of Estimates The preparation of our unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions. Furthermore, when testing assets for impairment in future periods, if management uses different assumptions or if different conditions occur, impairment charges may result. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company's business and markets. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including revenues, expenses, reserves and allowances, fair value measurements and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the pandemic, its severity in our markets and elsewhere, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume. Concentrations of Credit Risk Financial instruments that potentially subject us to significant concentrations of credit risk consisted primarily of cash, accounts receivable and revenue. Customer and Revenue Concentrations During the three months ended March 31, 2023, 88% of SevenFive’s revenue was with three customers. During the three months ended March 31, 2022, 45% of SevenFive’s revenue was with one customer. The customers in both 2023 and 2022 are related party dispensaries and the revenues associated with these customers are eliminated in consolidation. During the three months ended March 31, 2023, 88% of Green Tree’s revenue was with three customers. The customers in 2023 are related party dispensaries and the revenues associated with these customers are eliminated in consolidation. Going Concern We incurred net losses of $1,886,534 during the three months ended March 31, 2023, and $861,056 for the three months ended March 31, 2022, and had an accumulated deficit of $95,288,616 as of March 31, 2023. We had cash and cash equivalents of $1,460,162 and $2,583,833 as of March 31, 2023, and December 31, 2022, respectively. The accompanying unaudited condensed consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities and commitments in the ordinary course of business. We have incurred recurring losses and negative cash flows from operations since inception and have primarily funded our operations with proceeds from the issuance of convertible debt. We expect our operating losses to continue into the foreseeable future as we continue to execute our acquisition and growth strategy. As a result, we have concluded that there is substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our ability to continue as a going concern is dependent upon our ability to raise additional capital to fund operations, support our planned investing activities, and repay our debt obligations as they become due. If we are unable to obtain additional funding, we would be forced to delay, reduce, or eliminate some or all of our acquisition efforts, which could adversely affect our growth plans. Summary of Significant Accounting Policies See our Annual Report on Form 10-K for the year ended December 31, 2022, for discussion of the Company's significant accounting policies. Recently Issued Accounting Standards FASB ASU 2020-06 – “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”- In June 2020, the Financial Accounting Standards Board (“FASB”) issued guidance which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Accounting Standards Updates (“ASU”) also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share calculation in certain areas. The amendments in this ASU are effective for annual and interim periods beginning after December 15, 2023, although early adoption is permitted. We adopted this ASU in the first quarter of 2022, and the adoption did not have a material effect on our financial statements.

BUSINESS ACQUISITION

BUSINESS ACQUISITION	3 Months Ended
	Mar. 31, 2023
BUSINESS ACQUISITION
BUSINESS ACQUISITION	NOTE 2. BUSINESS ACQUISITION On December 12, 2022, we completed the Green Tree Acquisition which consisted of the acquisition of substantially all of the assets of Ancient Alternatives LLC, Natural Alternatives For Life, LLC, Mountainside Industries, LLC, Hillside Enterprises, LLC, and GT Creations, LLC, each a Colorado limited liability company (collectively, the "Green Tree Entities”). We assumed certain operating obligations at closing, including certain manufacturing agreements between GT Creations and affiliates of the Green Tree Entities. Allyson Feiler, a principal owner of the Green Tree Entities, was also elected to our Board of Directors effective the date of acquisition. ​ We paid cash in the amount of $500,000 and stock consideration of 17,977,528 shares of our Common Stock. The closing price of our Common Stock on December 12, 2022, the date of license transfer, was $0.165 per share, as such, fair value of the equity consideration is $2,966,292. An additional $3,500,000 in cash will be paid to the sellers in fifteen ​ The table below reflects the Company’s preliminary estimates of the acquisition date fair values of the assets acquired. ​ ​ ​ ​ ​ Cash $ 3,928 Inventory ​ ​ 1,588,454 Fixed assets ​ ​ 688,655 Tradename ​ ​ 950,000 Goodwill ​ 3,255,679 ​ ​ $ 6,486,716 ​ We have not completed the allocation of the purchase price for the Green Tree Acquisition. As of March 31, 2023, the consolidated balance sheet includes a preliminary allocation of fixed assets, inventory, intangible assets, and goodwill. Management anticipates completing the purchase price allocation as soon as possible, but no later than one year from the acquisition date. The accompanying consolidated financial statements include the results of the Green Tree Entities from the date of acquisition for financial reporting purposes, December 12, 2022. The pro forma effects of the acquisition on the results of operations as if the transaction had been completed on January 1, 2022, are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ 2023 ​ 2022 Total revenues ​ $ — ​ $ 5,976,828 Net income (loss) attributable to Common Stockholders ​ $ — ​ $ (854,259) Net income (loss) per common share ​ $ — ​ $ (0.01) Weighted average number of basic and diluted common shares outstanding ​ ​ — ​ ​ 113,727,033 ​ The unaudited pro-forma results of operations are presented for information purposes only. The unaudited pro-forma results are not intended to present actual results that would have been attained had the acquisition been completed as of January 1, 2022, or to project potential operating results as of any future date or for any future periods. ​ On December 19, 2022, we completed the Green Man Acquisition, consisting of the acquisition of substantially all of the assets of Green Man. We paid cash in the amount of $1,225,000 and stock consideration of 4,494,382 shares of Common Stock. The closing price of our Common Stock on December 19, 2022, the date of license transfer, was $0.18 per share, as such, fair value of the equity consideration is $808,989. An additional $1,500,000 in cash will be paid to the sellers in eighteen ​ The table below reflects the Company’s preliminary estimates of the acquisition date fair values of the assets acquired: ​ ​ ​ ​ ​ Cash $ 8,594 Inventory ​ ​ 108,543 Fixed assets ​ ​ 23,500 Tradename ​ ​ 150,000 Goodwill ​ 2,968,198 ​ ​ $ 3,258,835 ​ We have not completed the allocation of the purchase price for the Green Man Acquisition. As of March 31, 2023, the consolidated balance sheet includes a preliminary allocation of fixed assets, inventory, intangible assets, and goodwill. Management anticipates completing the purchase price allocation as soon as possible, but no later than one year from the acquisition date. The accompanying consolidated financial statements include the results of Green Man from the date of acquisition for financial reporting purposes, December 19, 2022. The pro forma effects of the acquisition on the results of operations as if the transaction had been completed on January 1, 2022, are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ 2023 ​ 2022 Total revenues ​ $ — ​ $ 5,010,218 Net income (loss) attributable to Common Stockholders ​ $ — ​ $ (950,487) Net income (loss) per common share ​ $ — ​ $ (0.01) Weighted average number of basic and diluted common shares outstanding ​ ​ — ​ ​ 100,243,887 ​ The unaudited pro-forma results of operations are presented for information purposes only. The unaudited pro-forma results are not intended to present actual results that would have been attained had the acquisition been completed as of January 1, 2022, or to project potential operating results as of any future date or for any future periods.

ASSET ACQUISITION

ASSET ACQUISITION	3 Months Ended
	Mar. 31, 2023
ASSET ACQUISITION
ASSET ACQUISITION	NOTE 3. ASSET ACQUISITION ​ In February 2023, we completed the acquisition of the assets of Station 2, LLC. The assets consist of a medical and retail cannabis license for a dispensary located in Denver, CO. We also assumed responsibility of the operating lease for the dispensary and recorded the relating ROU asset which is disclosed separately on the accompanying consolidated balance sheets. The consideration paid by the Company consists of cash at closing equal to $256,582 plus an additional $385,873 in twenty-four (24) equal monthly payments commencing May 2023. As the dispensary was not in operation and there was no assembled workforce at the time of acquisition, the acquisition was accounted for as an asset acquisition of a license. As of March 31, 2023, the balance of the license was $580,694 , which is recorded within Intangible assets, net in our condensed consolidated balance sheets.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	3 Months Ended
	Mar. 31, 2023
DISCONTINUED OPERATIONS
DISCONTINUED OPERATIONS	​ NOTE 4. DISCONTINUED OPERATIONS On July 16, 2021, we entered into an Asset Purchase Agreement with an individual to sell substantially all of the assets of NBC for a total of $150,000 and 10% of profits generated by the buyer in the states of Michigan, Mississippi, and Massachusetts for a period of twelve months from the closing. On August 2, 2021, the sale of NBC was completed. Pursuant to amendment, the buyer paid the additional A summary of the discontinued operations for the Operations Segment is presented as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ ​ March 31, ​ ​ 2023 2022 ​ Product revenues ​ $ — ​ $ 3,438 Service revenues ​ ​ — ​ ​ — ​ Total revenues ​ ​ — ​ ​ 3,438 ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of sales ​ — ​ — ​ Selling, general and administrative ​ — ​ (1,845) ​ Professional fees ​ — ​ — ​ Depreciation and amortization ​ ​ — ​ ​ — ​ Total costs and expenses ​ — ​ (1,845) ​ Income from discontinued operations ​ $ — ​ $ 5,283 ​ ​

INVENTORIES, NET

INVENTORIES, NET	3 Months Ended
	Mar. 31, 2023
INVENTORIES, NET
INVENTORIES, NET	NOTE 5. INVENTORIES, NET Our inventories consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ December 31, ​ 2023 2022 Raw materials ​ $ 8,883 ​ $ 8,883 Work-in-progress and finished goods ​ ​ 2,404,232 ​ ​ 2,057,779 Inventories ​ $ 2,413,115 ​ $ 2,066,662 ​

LEASES

LEASES	3 Months Ended
	Mar. 31, 2023
LEASES
LEASES	NOTE 6. LEASES The Company’s leases consist primarily of real estate leases for retail, cultivation, and manufacturing facilities. All but one of the Company’s leases are classified as operating leases. The lease for the retail dispensary acquired in the Green Man Transaction is classified as a finance lease. The current and non-current portions of the operating lease liabilities and finance lease liabilities are disclosed separately on the accompanying consolidated balance sheets. The finance lease ROU asset is included in property and equipment, net and the operating lease ROU asset is disclosed separately on the accompanying consolidated balance sheets. As the rate implicit in the Company’s leases is not readily determinable, we used an estimated incremental borrowing rate of 20% in determining the present value of lease payments. ​ The operating lease expense for the three months ended March 31, 2023, and March 31, 2022, is as follows: ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended March 31, 2023 2022 Straight-line operating lease expense ​ $ 393,265 ​ $ 192,016 Variable lease cost ​ ​ 202,826 ​ ​ 15,282 Total operating lease expense ​ $ 596,091 ​ $ 207,298 ​ The finance lease expense for the three months ended March 31, 2023, and March 31, 2022, was approximately $50,000 and nil, respectively. Related party lease As of March 31, 2023, three of the Company’s operating leases, one retail dispensary lease, one cultivation facility lease, and one lease that includes both cultivation and retail, are related party leases as the landlords are current, and former, board members, principal shareholders, or employees. During the three months ended Mach 31, 2022, the related party operating leases consisted of one dispensary and one cultivation facility. The retail dispensary lease was with a related party through May 2022, when the building was sold to an unaffiliated third-party. As of March 31, 2023, the ROU asset, operating lease liability, current, and operating lease liability, non-current for the related party leases were $1,002,335, $529,299, and $539,267, respectively. For the periods ended March 31, 2023 and 2022, the total lease expense for related party leases was $127,790 and $147,937, respectively. Lease Maturities Future remaining minimum lease payments were as follows: ​ ​ ​ ​ ​ ​ ​ ​ Year ending December 31, Operating leases ​ Finance lease 2023 (remaining nine months) ​ $ 1,184,542 ​ $ 150,000 2024 ​ 1,617,657 ​ 205,400 2025 ​ 1,309,970 ​ 171,043 2026 ​ 846,823 ​ 136,940 2027 ​ ​ 507,871 ​ ​ 143,102 Thereafter ​ 965,354 ​ 818,100 Total ​ 6,432,217 ​ 1,624,585 Less: Present value adjustment ​ (2,274,659) ​ (875,080) Lease liability ​ ​ 4,157,558 ​ ​ 749,505 Less: Lease liability, current ​ ​ (843,431) ​ ​ (60,008) Lease liability, non-current ​ $ 3,314,127 ​ $ 689,497 ​ The total remaining lease payments in the table above include $2,995,100 related to renewal option periods that management is reasonably certain will be exercised. The majority of this amount relates to the flagship Trees location in Englewood, Colorado and the retail and certain cultivation facilities that were acquired in the Green Tree Acquisition and are eligible for renewal in 2023. As of March 31, 2023, the weighted average remaining term of the Company’s operating leases is 4.5 years, and the remaining term on the finance lease is 9.75 years. None of the Company’s leases contain residual value guarantees or restrictive covenants. Supplemental cash flow information ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended March 31, 2023 2022 Supplemental cash flow information ​ ​ ​ ​ ​ ​ Cash paid for amounts included in operating lease liability ​ $ 373,840 ​ $ 170,276 Cash paid for amounts included in finance lease liability ​ $ 50,000 ​ $ — Supplemental lease disclosures of non-cash transactions: ​ ​ ​ ​ ​ ​ ROU assets obtained in exchange for operating lease liabilities ​ $ 348,825 ​ $ 172,053 ​

ACCRUED STOCK PAYABLE

ACCRUED STOCK PAYABLE	3 Months Ended
	Mar. 31, 2023
ACCRUED STOCK PAYABLE
ACCRUED STOCK PAYABLE	NOTE 7. The following tables summarize the changes in accrued common stock payable: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ Amount Shares Balance as of December 31, 2021 ​ $ 444,894 ​ ​ 1,769,537 Stock issued ​ ​ (383,994) ​ ​ (1,669,537) Balance as of December 31, 2022 ​ $ 60,900 ​ ​ 100,000 Stock issued ​ ​ — ​ ​ — Balance as of March 31, 2023 ​ $ 60,900 ​ ​ 100,000 ​ In December 2021, we completed the acquisition of Trees Waterfront. As part of the transaction, we granted shares of our common stock. The stock was issued on January 6, 2022. The outstanding balance of accrued stock payable as of March 31, 2023 relates to a February 18, 2020 grant of 100,000 fully vested shares for consulting services. Based on a stock price of $0.61 on the date of grant, the consultant will receive $60,900 worth of our Common Stock. As of March 31, 2023, none of the stock has been issued.

NOTES PAYABLE

NOTES PAYABLE	3 Months Ended
	Mar. 31, 2023
NOTES PAYABLE
NOTES PAYABLE	NOTE 8. NOTES PAYABLE Our notes payable consisted of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2023 ​ December 31, 2022 ​ Third-party ​ Related-party ​ Total ​ Third-party ​ Related-party ​ Total 2022 12% Notes $ 13,167,796 ​ $ 332,204 ​ $ 13,500,000 ​ $ 13,167,796 ​ $ 332,204 ​ $ 13,500,000 2023 12% Notes ​ — ​ ​ 384,873 ​ ​ 384,873 ​ ​ — ​ ​ — ​ ​ — Trees Transaction Notes ​ — ​ ​ 864,977 ​ ​ 864,977 ​ ​ — ​ ​ 1,191,865 ​ ​ 1,191,865 Green Tree Acquisition Notes ​ 774,750 ​ ​ 2,725,250 ​ ​ 3,500,000 ​ ​ 774,750 ​ ​ 2,725,250 ​ ​ 3,500,000 Green Man Acquisition Notes ​ 1,500,000 ​ ​ — ​ ​ 1,500,000 ​ ​ 1,500,000 ​ ​ — ​ ​ 1,500,000 Unamortized debt discount ​ (1,399,890) ​ ​ (358,287) ​ ​ (1,758,177) ​ ​ (1,527,346) ​ ​ (361,587) ​ ​ (1,888,933) Total debt ​ 14,042,656 ​ ​ 3,949,017 ​ ​ 17,991,673 ​ ​ 13,915,200 ​ ​ 3,887,732 ​ ​ 17,802,932 Less: Current portion ​ (466,853) ​ ​ (1,412,320) ​ ​ (1,879,173) ​ ​ (179,827) ​ ​ (1,723,517) ​ ​ (1,903,344) Long-term portion $ 13,575,803 ​ $ 2,536,697 ​ $ 16,112,500 ​ $ 13,735,373 ​ $ 2,164,215 ​ $ 15,899,588 ​ Trees Transaction Notes In January 2022, with the completion of the Trees MLK acquisition, we are obligated to pay the Seller cash equal to $384,873 in equal month installments over a period of 24 months. The payments began on June 15, 2022 and the payment is equal to $16,036 per month. In December 2022, with the completion of the Green Tree Acquisition, we are obligated to pay the Seller cash equal to $3,500,000 in equal month installments over a period of 15 months. The payments begin in September 2023, and the payment is equal to $233,333 per month. The relative fair value of this obligation resulted in a debt discount of $512,367. We recorded amortization of debt discount expense from this obligation of $61,016 and nil for the three months ended March 31, 2023 and March 31, 2022, respectively. In December 2022, with the completion of the Green Man Acquisition, we are obligated to pay the Seller cash equal to $1,500,000 in equal month installments over a period of 18 months. The payments begin in December 2023 and the payment is equal to $83,333 per month. The relative fair value of this obligation resulted in a debt discount of $275,154. We recorded amortization of debt discount expense from this obligation of $37,250 and nil for the three months ended March 31, 2023 and March 31, 2022, respectively. 12% Notes On September 15, 2022, we entered into a Securities Purchase Agreement with certain accredited investors (the “12% Investors”), pursuant to which we agreed to issue and sell senior secured convertible notes (the “12% Notes”) with an aggregate principal amount of $13,500,000 to such 12% Investors, in exchange for payment by certain 12% Investors of an aggregate amount of $10,587,250 in cash, as well as cancellation of outstanding indebtedness in the aggregate amount of $2,912,750 represented by the 10% Notes discussed below. ​ In connection with the 12% Notes, the 12% Investors received warrants (the “12% Warrants”) to purchase shares of our common stock equal to 20% coverage of the aggregate principal amount with an exercise price of $0.70 per share, which equals an aggregate of warrants to purchase 3,857,150 shares of Common Stock. The lead shares of Common Stock. The lead Notes. This total fee in the amount of was recorded as a debt discount and will be amortized over the life of the loan. The and will mature on September 16, 2026. The per share. ​ The relative fair value of the new funding on the 12% Warrants was recorded as a debt discount and additional paid-in capital of $569,223 . The relative fair value of the cancellation of the outstanding indebtedness was recorded as an extinguishment of debt and additional paid-in capital of . We recorded amortization of debt discount expense from the for the three months ended March 31, 2023 and 2022, respectively. We determined there was no beneficial conversion feature on the Notes issued. The For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 12% Warrants as of September 15, 2022, were: ​ ​ ​ ​ Current stock price $ 0.20 Exercise price ​ $ 0.70 Risk-free interest rate ​ ​ 3.66% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 107% ​ In connection with the acquisition of Station 2, LLC in February 2023, we agreed to issue and sell an additional 12% Note with an aggregate principal amount of $385,873, payable in twenty-four 10% Notes In December 2020, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement’) with certain accredited investors (the “10% Investors”), pursuant to which we issued and sold senior convertible promissory notes (the “10% Notes”) with an aggregate principal amount of $2,940,000 in exchange for payment to us by certain 10% Investors of an aggregate amount of $1,940,000 in cash, as well as cancellation of outstanding indebtedness of previously issued 15% notes in the aggregate amount of $1,000,000 . In connection with the issuance of the per share. In the aggregate, this equals shares of our common stock. The and will mature on December 23, 2023. The per share. The The relative fair value of the new funding on the 10% Warrants was recorded as a debt discount and additional paid-in capital of $254,400. The relative fair value of the cancellation of the outstanding indebtedness was recorded as an extinguishment of debt and additional paid-in capital of $131,000. We recorded amortization of debt discount expense from the 10% Notes of nil and $21,393 for the three months ended March 31, 2023 and 2022. We determined there was Notes issued in December 2020. The For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 10% Warrants as of December 23, 2020, were: ​ ​ ​ ​ ​ Current stock price $ 0.53 Exercise price ​ $ 0.56 Risk-free interest rate ​ ​ 0.38% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 115% ​ On February 8, 2021, we entered into a Securities Purchase Agreement with an accredited 10% Investor, pursuant to which we issued and sold 10% Notes with an aggregate principal amount of $1,660,000 to such 10% Investor. The 10% Notes are part of an over-allotment option exercised by us in connection with the convertible note offering consummated on December 23, 2020, as discussed above. In connection with the issuance of the 10% Notes, the holder received warrants to purchase shares of our common stock equal to 20% coverage of the aggregate principal amount at $0.56 per share. In the aggregate, this equals 592,858 shares of our common stock with a par value $0.001 per share. The at a variable price of 80% of the market price but no less than $0.65 per share and no more than $1.00 per share. The relative fair value of the new funding on the 10% Warrants was recorded as a debt discount and additional paid-in capital of $429,300 . We determined that this as additional paid in capital and a debt discount and included in our consolidated statement of operations. We recorded amortization of debt discount expense from the February 2021 for the three months ended March 31, 2023 and 2022, respectively. The For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 10% Warrants as of February 8, 2021, were: ​ ​ ​ ​ ​ Current stock price $ 1.12 Exercise price ​ $ 0.56 Risk-free interest rate ​ ​ 0.48% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 118% ​ On April 20, 2021, we entered into a Securities Purchase Agreement with accredited 10% Investors, pursuant to which we issued and sold 10% Notes with an aggregate principal amount of $2,300,000 to such 10% Investors. The consummated on December 23, 2020, and February 8, 2021. In connection with the issuance of the of the aggregate principal amount invested. The and will mature on April 20, 2024. The per share. The ​ The relative fair value of the new funding on the 10% Warrants was recorded as a debt discount and additional paid-in capital of $810,000 . We determined that these as additional paid in capital and a debt discount and included in our consolidated statement of operations. We recorded amortization of debt discount expense from the April 2021 for the three months ended March 31, 2023 and 2022. The For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 10% Warrants as of April 20, 2021, were: ​ ​ ​ ​ ​ Current stock price $ 0.83 Exercise price ​ $ 0.56 Risk-free interest rate ​ ​ 0.81% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 115% ​ ​ ​ ​ ​ ​ ​ In September 2022, $2,912,750 of the 10% Notes were exchanged for the 12% Notes (see above) and the remaining $3,987,250 was paid in full. Of the remaining debt discount,

WARRANT DERIVATIVE LIABILITY

WARRANT DERIVATIVE LIABILITY	3 Months Ended
	Mar. 31, 2023
WARRANT DERIVATIVE LIABILITY.
WARRANT DERIVATIVE LIABILITY	NOTE 9. WARRANT DERIVATIVE LIABILITY On May 31, 2019, we received gross proceeds of $3 million by issuing three million shares of our common stock and three million warrants (“2019 Warrants”) to purchase shares of our common stock (“2019 Units”) in a registered direct offering for $1.00 per 2019 Unit (collectively defined as the “2019 Capital Raise”). The 2019 Warrants, issued with the 2019 Capital Raise, are accounted for as a derivative liability. The 2019 Warrant agreements contain a cash settlement provision whereby the holders could settle the warrants for cash based on the Black-Scholes value, upon certain fundamental transactions, as defined in the 2019 Warrant agreement, which are considered outside of the control of management, such as a change of control. The original exercise price of the 2019 Warrants was $1.30 per share. The 2019 Warrants contain certain anti-dilution adjustment provisions with respect to subsequent issuances of securities by the Company at a price below the exercise price of such warrants. As a result of such subsequent issuances of securities by the Company during the fourth quarter 2019, the exercise price of the 2019 Warrants decreased to $0.45 per share and the number of shares subject to the 2019 Warrants increased to 8,666,666 shares of common stock as of December 31, 2019. In May 2020, we issued securities at a price lower than the $0.45 per share above. As a result, the exercise price of the 2019 Warrants decreased to $0.3983 per share and the number of shares subject to the 2019 Warrants increased to 9,591,614 shares of common stock. During the first quarter of 2021 the warrant holders exercised 1,323,000 warrants into 747,208 shares of our common stock through cashless exercise. We recorded an adjustment to the derivative liability of as a result. During the three months ended March 31, 2023, and 2022, we recognized a $1,307 gain and $60,664 loss on the change in fair value of the derivative liability, respectively. As of March 31, 2023, there were 322,807 of the 2019 Warrants outstanding. The following are the key assumptions that were used to determine the fair value of the 2019 Warrants ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ December 31, ​ ​ 2023 ​ 2022 Number of shares underlying the warrants ​ ​ 322,807 ​ ​ 322,807 ​ Fair market value of stock ​ $ 0.16 ​ $ 0.15 ​ Exercise price ​ $ 0.40 ​ $ 0.40 ​ Volatility ​ ​ 73 % 78 % Risk-free interest rate ​ ​ 4.64 % 3.99 % Warrant life (years) ​ ​ 1.16 ​ 1.41 ​ ​ The following table sets forth a summary of the changes in the fair value of the warrant derivative liability, our Level 3 financial liabilities that are measured at fair value on a recurring basis: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ ​ 2023 2022 ​ Beginning balance ​ $ 5,508 ​ $ 28,317 ​ Warrant exercise ​ ​ — ​ ​ — ​ Change in fair value of warrants derivative liability ​ ​ (1,307) ​ ​ 60,664 ​ Ending balance ​ $ 4,201 ​ $ 88,981 ​ ​

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2023
COMMITMENTS AND CONTINGENCIES.
COMMITMENTS AND CONTINGENCIES	NOTE 10. COMMITMENTS AND CONTINGENCIES From time to time, the Company is a party to various litigation matters incidental to the conduct of its business. The Company is not presently a party to any legal proceedings that would have a material adverse effect on its business, operating results, financial condition, or cash flows, except as set forth below. In July 2021, we were served with a Complaint in the District Court, County of Denver, Colorado, by plaintiff 2353 SB, LLC (“Plaintiff”). We entered into a lease with Plaintiff for the premises at 2353 South Broadway, Denver, CO with a term of three We have taken the position that our failure to take possession and make any further payments under the lease is directly related to the COVID-19 pandemic. We are vigorously defending this action and believe that the above-referenced force majeure clause presents a complete defense to Plaintiff’s claims. ​ We filed a motion to dismiss or a motion for summary judgment in the alternative. Plaintiff filed a response and cross-motion for summary judgment thereafter. In October 2022, the court denied the motion to dismiss on the basis that Plaintiff sufficiently pled facts that raise a plausible claim for relief, notwithstanding our possible defenses, but has not specifically made any rulings on either party’s motion for summary judgment. On November 14, 2022, we timely filed a formal answer to the complaint, denying each of Plaintiff’s substantive claims. We also asserted appropriate affirmative defenses, including the force majeure clause of the lease, which provides that we are not liable under the lease in the event of a variety of events outside our control, including “pandemics.” In addition, we have asserted a counterclaim against the Plaintiff for breach of contract to recover the initial payments made under the lease as well as attorneys’ fees and costs. The trial is currently scheduled for September 2023.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2023
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	NOTE 11. STOCKHOLDERS’ EQUITY 2021 Preferred stock offering On September 10, 2021, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with various accredited investors (the “2021 Investors), pursuant to which we issued and sold Units consisting of Series A Convertible Preferred Stock (“Series A Preferred”) and warrants (the “Preferred Warrants”) to purchase shares of our common stock with a par value of $0.001 per share. The total number of Units sold was . Each Unit consists of Preferred Warrants. The purchase price of each Unit was . Each share of Series A Preferred is convertible into . The Certificate of Designation of the Series A Preferred Stock (“Certificate of Designation”) was filed with the Secretary of the State of Colorado on September 14, 2021. The Certificate of Designations established the new preferred series entitled “Series A Convertible Preferred Stock” with ● Authorized Number of Shares – 5,000 ● Voting Rights – None ● Dividends – 6% per annum, ‘paid in kind’ in shares of Series A Preferred ● Conversion – Each share of Series A Preferred is mandatorily convertible into 1,000 shares of common stock upon a minimum capital raise of $5,000,000 ; sale, merger or business combination of the Company; or the Company listing on an exchange ● Redemption – No rights of redemption by 2021 Investors, nor mandatory redemption The Preferred Warrants have a five-year term and an exercise price per Preferred Warrant share of $1.05 . The warrants contain an anti-dilution provision pursuant to which upon a future capital raise at less than The proceeds received in the sale of the Series A Preferred totaled $1,180,000, for the issuance of 1,180 Series A Preferred, plus 354,000 warrants. The warrants were valued using a Black Scholes model, at As of March 31, 2023 we have recorded accrued dividends of $106,200. Stock-based compensation We use the fair value method to account for stock-based compensation on the grant date. We recorded in compensation expense for the three months ended March 31, 2023 and 2022, respectively. This includes expense related to options issued in prior years for which the requisite service period for those options includes the current period as well as options issued in the current period. Forfeited options result in a reversal in the period forfeited. The fair value of these instruments was calculated using the Black-Scholes option pricing method. During the year ended December 31, 2022, we granted options to purchase 250,000 common shares to directors. The options expire . Fair value of the awards at the date of grants totaled The following summarizes Employee Awards activity: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted- ​ ​ ​ ​ ​ ​ ​ Weighted- ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Number of ​ Exercise Price ​ Contractual ​ Aggregate ​ Shares per Share Term (in years) Intrinsic Value Outstanding as of December 31, 2022 ​ 4,936,825 ​ $ 1.08 ​ 4.4 ​ $ 22,000 Granted ​ — ​ ​ — ​ ​ ​ Forfeited or expired — ​ — ​ Outstanding as of March 31, 2023 4,936,825 $ 1.08 4.4 ​ $ 22,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable as of March 31, 2023 4,776,945 ​ $ 1.11 4.4 ​ $ 4,000 ​ As of March 31, 2023, there was approximately $722 of total unrecognized compensation expense related to unvested employee awards, which is expected to be recognized over a weighted-average period of fourteen months. On April 1, 2022 we entered into a Restricted Stock Unit Agreement with four participants. The Restricted Stock Unit’s (“RSU”) were granted pursuant to our 2020 Omnibus Incentive Plan. RSU’s. The equal tranches of RSU’s. Each tranche RSU will vest immediately if and upon the market price reaching a certain minimum market price of our common stock as reported on the OTCQB market. Each tranche will vest as the market price reaches . Upon the RSU’s vesting, the participant will be promptly issued shares of our common stock. If there is a change in control, all unvested RSU’s granted under this agreement will become fully vested and the vested RSU’s will be paid out or settled. The fair value of these instruments is and was calculated using the Monte Carlo model. The fair value of the RSU’s is recognized over the requisite service period. As these RSU’s do not have a service period, we used the requisite service period derived from the valuation of . We recorded in compensation expense for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023,

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2023
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 12. RELATED PARTY TRANSACTIONS On September 16, 2022, the Company entered into a new consulting agreement with Adam Hershey, its Interim Chief Executive Officer, pursuant to which Mr. Hershey will continue to serve as the Company’s Interim Chief Executive Officer with compensation equal to $200,000 per annum, payable by the Company, monthly. The term of the consulting agreement is for a period of until, May 29, 2027. The exercise price and all other terms and conditions of such warrants remain unchanged. We paid In February 2023, the Company completed the acquisition of Station 2, LLC’s assets. Station 2, LLC is owned by a board member, who is also a shareholder and executive level employee of the Company. See Note 3 for additional information regarding the Station 2 asset acquisition. The Company currently has a lease agreement with Dalton Adventures, LLC in which the Company leases 17,000 square feet of greenhouse space in Boulder, Colorado for $29,691 a month, of which $27,000 is base rent and $2,691 is property taxes. The base rent increased to $27,405 per month starting in January 2023. The owner of Dalton Adventures, LLC is a principal shareholder and former board member of the Company. We have incurred The Company currently has a lease agreement with JLA Enterprises, LLC in which the Company leases a retail dispensary in Longmont, Colorado. A board member and an executive level employee of the Company are owners of JLA Enterprises, LLC. The Company also has a lease agreement with ALJ 1090, LLC in which the Company leases a building that has a retail dispensary and cultivation facility in Berthoud, Colorado. The same board member is an owner of ALJ 1090, LLC. These leases were assumed as part of the Green Tree Acquisition on December 12, 2022. We have incurred $51,942 and nil in related party lease expense for the three months ended March 31, 2023 and 2022, respectively. See Note 6 for further discussion of the Company’s obligations associated with related party leases. The Company had a lease agreement with Bellewood Holdings, LLC in which the Company leased retail space for the Trees Englewood retail store in Englewood, Colorado for $11,287 per month, of which $10,000 is base rent and $1,287 is property taxes. The owner of Bellewood Holdings, LLC is a principal shareholder and board member of the Company. In June 2022, the building was sold to an unrelated party. We incurred See Note 6 for further discussion of the Company’s obligations associated with related-party leases.

SEGMENT INFORMATION

SEGMENT INFORMATION	3 Months Ended
	Mar. 31, 2023
SEGMENT INFORMATION
SEGMENT INFORMATION	NOTE 13. SEGMENT INFORMATION Our operations are organized into two segments: Retail and Cultivation. All revenue originates, and all assets are located in the United States. Segment information is presented in accordance with ASC 280, "Segments Reporting." Three months ended March 31, ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2023 Retail Cultivation Eliminations ​ Total Revenues ​ $ 5,110,619 ​ $ 684,017 ​ $ (684,017) ​ $ 5,110,619 Costs and expenses ​ ​ (4,535,568) ​ ​ (1,139,573) ​ ​ 684,017 ​ ​ (4,991,124) Segment operating income ​ $ 575,051 ​ $ (455,556) ​ $ — ​ ​ 119,495 Corporate expenses ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (1,920,293) Net loss from continuing operations before income taxes ​ ​ ​ ​ ​ ​ ​ ​ ​ $ (1,800,798) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2022 Retail Cultivation ​ Eliminations Total Revenues ​ $ 3,297,544 ​ $ 518,280 ​ $ (242,516) ​ $ 3,573,308 Costs and expenses ​ ​ (2,593,269) ​ ​ (707,549) ​ ​ 242,516 ​ ​ (3,058,302) Segment operating income ​ $ 704,275 ​ $ (189,269) ​ $ — ​ ​ 515,006 Corporate expenses ​ ​ ​ ​ ​ ​ ​ (1,381,345) Net loss from continuing operations before income taxes ​ ​ ​ ​ ​ ​ ​ ​ ​ $ (866,339) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ December 31, Total assets 2023 2022 Retail ​ $ 25,691,073 ​ $ 25,212,245 Cultivation ​ ​ 4,925,079 ​ ​ 4,628,452 Corporate ​ 1,147,566 ​ 1,985,455 Total assets - segments ​ ​ 31,763,718 ​ ​ 31,826,152 Intercompany eliminations ​ ​ (336,354) ​ ​ (131,439) Total assets - consolidated ​ $ 31,427,364 ​ $ 31,694,713 ​

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 14. SUBSEQUENT EVENTS The Company evaluated subsequent events through the date that the accompanying financial statements were issued and has determined that subsequent to March 31, 2023, the Company issued 201,250 restricted stock units. Each restricted stock unit will vest for a period of seven years from the respective grant date and upon vesting will convert into one share of common stock. ​ ​

NATURE OF OPERATIONS, HISTORY_2

NATURE OF OPERATIONS, HISTORY AND PRESENTATION (Policies)	3 Months Ended
	Mar. 31, 2023
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
Nature of Operations	Nature of Operations TREES Corporation, a Colorado Corporation (the “Company,” “we,” “us,” or “our,”) is a cannabis retailer and cultivator in the States of Colorado and Oregon. We presently operate eight (8) cannabis dispensaries as follows: ● Englewood, Colorado o 5005 S. Federal Boulevard – Recreational license only ● Two (2) in Denver, Colorado o 468 S. Federal Boulevard – Recreational license only o East Hampden Avenue (formerly Green Man) – Recreational license only ● Longmont, Colorado o 12626 N. 107 th Street (formerly Green Tree/Ancient Alternatives) – Medical and Recreational licenses ● Berthoud, Colorado o 1090 N. 2 nd Street (formerly Green Tree/Natural Alternatives for Life) – Medical and Recreational licenses ● Three (3) in Oregon o SW Corbett Avenue, Portland, OR – Medical and Recreational licenses o NE 102 nd Avenue, Portland, OR – Medical and Recreational licenses o 7050 NE MLK, Portland, OR – Medical and Recreational licenses ​ ​ We also operate five (5) cultivation facilities in Colorado as follows: ● SevenFive Farm – 3705 N. 75 th Street, Boulder – Retail cultivation license only ● 6859 N. Foothills Highway D-300 (formerly Green Tree/Ancient Alternatives) – Medical and Retail cultivation licenses ● 6859 N. Foothills Highway C-100 (formerly Green Tree/Mountainside Industries) – Medical and Retail cultivation licenses ● 6859 N. Foothills Highway E-100 (formerly Green Tree/Hillside Enterprises) – Retail cultivation license only ● 1090 N. 2 nd Street (formerly Green Tree/Natural Alternatives for Life) – Medical cultivation license only ​ Our principal business model is to acquire, integrate and optimize cannabis companies in the retail and cultivation segments utilizing the combined experience of entrepreneurs and synergistic operations of our vertically integrated network. Discontinued Operations - Operations Consulting and Products (“Operations Segment”) Through Next Big Crop (“NBC”), we delivered comprehensive consulting services to the cannabis industry that included obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and construction, and expansion of existing operations. ​ NBC oversaw our wholesale equipment and supply business, operating under the name “GC Supply,” which provided turnkey sourcing and stocking services to cultivation, retail, and infused products manufacturing facilities. Our products included building materials, equipment, consumables, and compliance packaging. NBC also provided operational support for our internal cultivation. On July 16, 2021, we entered into an Asset Purchase Agreement with an individual to sell substantially all the assets of NBC for a total of $150,000 and 10% of profits generated by the buyer in the states of Michigan, Mississippi, and Massachusetts for a period of twelve months from the closing. On August 2, 2021, the sale of NBC was completed. Pursuant to amendment, the buyer paid the additional
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements include all accounts of the Company and its wholly owned subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. These unaudited condensed consolidated financial statements have been prepared following the requirements of the Securities and Exchange Commission for interim reporting. As permitted under those rules, certain footnotes and other financial information that are normally required by accounting principles generally accepted in the United States of America ("U.S. GAAP") can be condensed or omitted. The condensed consolidated balance sheet for the year ended December 31, 2022, was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The information included in this quarterly report on Form 10-Q should be read in conjunction with the audited consolidated financial statements and notes thereto of the Company for the year ended December 31, 2022, which were included in the annual report on Form 10-K filed by the Company on April 17, 2023. In the opinion of management, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and notes thereto of the Company and include all adjustments, consisting only of normal recurring adjustments, considered necessary for the fair presentation of the Company's financial position and operating results. The results for the three months ended March 31, 2023, are not necessarily indicative of the operating results for the year ending December 31, 2023, or any other interim or future periods. Since the date of the Annual Report, there have been no material changes to the Company’s significant accounting policies.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.
Use of Estimates	Use of Estimates The preparation of our unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions. Furthermore, when testing assets for impairment in future periods, if management uses different assumptions or if different conditions occur, impairment charges may result. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company's business and markets. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations, and financial condition, including revenues, expenses, reserves and allowances, fair value measurements and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the pandemic, its severity in our markets and elsewhere, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject us to significant concentrations of credit risk consisted primarily of cash, accounts receivable and revenue. Customer and Revenue Concentrations During the three months ended March 31, 2023, 88% of SevenFive’s revenue was with three customers. During the three months ended March 31, 2022, 45% of SevenFive’s revenue was with one customer. The customers in both 2023 and 2022 are related party dispensaries and the revenues associated with these customers are eliminated in consolidation. During the three months ended March 31, 2023, 88% of Green Tree’s revenue was with three customers. The customers in 2023 are related party dispensaries and the revenues associated with these customers are eliminated in consolidation.
Going Concern	Going Concern We incurred net losses of $1,886,534 during the three months ended March 31, 2023, and $861,056 for the three months ended March 31, 2022, and had an accumulated deficit of $95,288,616 as of March 31, 2023. We had cash and cash equivalents of $1,460,162 and $2,583,833 as of March 31, 2023, and December 31, 2022, respectively. The accompanying unaudited condensed consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities and commitments in the ordinary course of business. We have incurred recurring losses and negative cash flows from operations since inception and have primarily funded our operations with proceeds from the issuance of convertible debt. We expect our operating losses to continue into the foreseeable future as we continue to execute our acquisition and growth strategy. As a result, we have concluded that there is substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our ability to continue as a going concern is dependent upon our ability to raise additional capital to fund operations, support our planned investing activities, and repay our debt obligations as they become due. If we are unable to obtain additional funding, we would be forced to delay, reduce, or eliminate some or all of our acquisition efforts, which could adversely affect our growth plans.
Recently Issued Accounting Standards	Recently Issued Accounting Standards FASB ASU 2020-06 – “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”- In June 2020, the Financial Accounting Standards Board (“FASB”) issued guidance which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Accounting Standards Updates (“ASU”) also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share calculation in certain areas. The amendments in this ASU are effective for annual and interim periods beginning after December 15, 2023, although early adoption is permitted. We adopted this ASU in the first quarter of 2022, and the adoption did not have a material effect on our financial statements.

BUSINESS ACQUISITION (Tables)

BUSINESS ACQUISITION (Tables)	3 Months Ended
	Mar. 31, 2023
Green Tree LLC
Schedule of purchase price allocation	​ ​ ​ ​ ​ Cash $ 3,928 Inventory ​ ​ 1,588,454 Fixed assets ​ ​ 688,655 Tradename ​ ​ 950,000 Goodwill ​ 3,255,679 ​ ​ $ 6,486,716 ​
Schedule of pro forma results of operations	​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ 2023 ​ 2022 Total revenues ​ $ — ​ $ 5,976,828 Net income (loss) attributable to Common Stockholders ​ $ — ​ $ (854,259) Net income (loss) per common share ​ $ — ​ $ (0.01) Weighted average number of basic and diluted common shares outstanding ​ ​ — ​ ​ 113,727,033 ​
Green Man Corp
Schedule of purchase price allocation	​ ​ ​ ​ ​ Cash $ 8,594 Inventory ​ ​ 108,543 Fixed assets ​ ​ 23,500 Tradename ​ ​ 150,000 Goodwill ​ 2,968,198 ​ ​ $ 3,258,835 ​
Schedule of pro forma results of operations	​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, ​ ​ 2023 ​ 2022 Total revenues ​ $ — ​ $ 5,010,218 Net income (loss) attributable to Common Stockholders ​ $ — ​ $ (950,487) Net income (loss) per common share ​ $ — ​ $ (0.01) Weighted average number of basic and diluted common shares outstanding ​ ​ — ​ ​ 100,243,887 ​

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	3 Months Ended
	Mar. 31, 2023
DISCONTINUED OPERATIONS
Schedule of net income (loss) from discontinued operations	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ ​ March 31, ​ ​ 2023 2022 ​ Product revenues ​ $ — ​ $ 3,438 Service revenues ​ ​ — ​ ​ — ​ Total revenues ​ ​ — ​ ​ 3,438 ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of sales ​ — ​ — ​ Selling, general and administrative ​ — ​ (1,845) ​ Professional fees ​ — ​ — ​ Depreciation and amortization ​ ​ — ​ ​ — ​ Total costs and expenses ​ — ​ (1,845) ​ Income from discontinued operations ​ $ — ​ $ 5,283 ​

INVENTORIES, NET (Tables)

INVENTORIES, NET (Tables)	3 Months Ended
	Mar. 31, 2023
INVENTORIES, NET
Schedule of inventories	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ December 31, ​ 2023 2022 Raw materials ​ $ 8,883 ​ $ 8,883 Work-in-progress and finished goods ​ ​ 2,404,232 ​ ​ 2,057,779 Inventories ​ $ 2,413,115 ​ $ 2,066,662

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2023
LEASES
Schedule of operating lease expense	​ ​ ​ ​ ​ ​ ​ ​ For the three months ended March 31, 2023 2022 Straight-line operating lease expense ​ $ 393,265 ​ $ 192,016 Variable lease cost ​ ​ 202,826 ​ ​ 15,282 Total operating lease expense ​ $ 596,091 ​ $ 207,298 ​
Schedule of future remaining minimum operating lease payments	​ ​ ​ ​ ​ ​ ​ ​ Year ending December 31, Operating leases ​ Finance lease 2023 (remaining nine months) ​ $ 1,184,542 ​ $ 150,000 2024 ​ 1,617,657 ​ 205,400 2025 ​ 1,309,970 ​ 171,043 2026 ​ 846,823 ​ 136,940 2027 ​ ​ 507,871 ​ ​ 143,102 Thereafter ​ 965,354 ​ 818,100 Total ​ 6,432,217 ​ 1,624,585 Less: Present value adjustment ​ (2,274,659) ​ (875,080) Lease liability ​ ​ 4,157,558 ​ ​ 749,505 Less: Lease liability, current ​ ​ (843,431) ​ ​ (60,008) Lease liability, non-current ​ $ 3,314,127 ​ $ 689,497 ​
Supplemental cash flow information	​ ​ ​ ​ ​ ​ ​ ​ For the three months ended March 31, 2023 2022 Supplemental cash flow information ​ ​ ​ ​ ​ ​ Cash paid for amounts included in operating lease liability ​ $ 373,840 ​ $ 170,276 Cash paid for amounts included in finance lease liability ​ $ 50,000 ​ $ — Supplemental lease disclosures of non-cash transactions: ​ ​ ​ ​ ​ ​ ROU assets obtained in exchange for operating lease liabilities ​ $ 348,825 ​ $ 172,053

ACCRUED STOCK PAYABLE (Tables)

ACCRUED STOCK PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2023
ACCRUED STOCK PAYABLE
Schedule of accrued common stock payable	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ Amount Shares Balance as of December 31, 2021 ​ $ 444,894 ​ ​ 1,769,537 Stock issued ​ ​ (383,994) ​ ​ (1,669,537) Balance as of December 31, 2022 ​ $ 60,900 ​ ​ 100,000 Stock issued ​ ​ — ​ ​ — Balance as of March 31, 2023 ​ $ 60,900 ​ ​ 100,000 ​

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2023
Class of Warrant or Right [Line Items]
Schedule of notes payable	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2023 ​ December 31, 2022 ​ Third-party ​ Related-party ​ Total ​ Third-party ​ Related-party ​ Total 2022 12% Notes $ 13,167,796 ​ $ 332,204 ​ $ 13,500,000 ​ $ 13,167,796 ​ $ 332,204 ​ $ 13,500,000 2023 12% Notes ​ — ​ ​ 384,873 ​ ​ 384,873 ​ ​ — ​ ​ — ​ ​ — Trees Transaction Notes ​ — ​ ​ 864,977 ​ ​ 864,977 ​ ​ — ​ ​ 1,191,865 ​ ​ 1,191,865 Green Tree Acquisition Notes ​ 774,750 ​ ​ 2,725,250 ​ ​ 3,500,000 ​ ​ 774,750 ​ ​ 2,725,250 ​ ​ 3,500,000 Green Man Acquisition Notes ​ 1,500,000 ​ ​ — ​ ​ 1,500,000 ​ ​ 1,500,000 ​ ​ — ​ ​ 1,500,000 Unamortized debt discount ​ (1,399,890) ​ ​ (358,287) ​ ​ (1,758,177) ​ ​ (1,527,346) ​ ​ (361,587) ​ ​ (1,888,933) Total debt ​ 14,042,656 ​ ​ 3,949,017 ​ ​ 17,991,673 ​ ​ 13,915,200 ​ ​ 3,887,732 ​ ​ 17,802,932 Less: Current portion ​ (466,853) ​ ​ (1,412,320) ​ ​ (1,879,173) ​ ​ (179,827) ​ ​ (1,723,517) ​ ​ (1,903,344) Long-term portion $ 13,575,803 ​ $ 2,536,697 ​ $ 16,112,500 ​ $ 13,735,373 ​ $ 2,164,215 ​ $ 15,899,588 ​
10% Warrants
Class of Warrant or Right [Line Items]
Summary of underlying assumptions used in the binomial lattice model to determine the fair value of Warrants	For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 10% Warrants as of December 23, 2020, were: ​ ​ ​ ​ ​ Current stock price $ 0.53 Exercise price ​ $ 0.56 Risk-free interest rate ​ ​ 0.38% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 115% ​ For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 10% Warrants as of February 8, 2021, were: ​ ​ ​ ​ ​ Current stock price $ 1.12 Exercise price ​ $ 0.56 Risk-free interest rate ​ ​ 0.48% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 118% ​ For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 10% Warrants as of April 20, 2021, were: ​ ​ ​ ​ ​ Current stock price $ 0.83 Exercise price ​ $ 0.56 Risk-free interest rate ​ ​ 0.81% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 115% ​
12% Warrants
Class of Warrant or Right [Line Items]
Summary of underlying assumptions used in the binomial lattice model to determine the fair value of Warrants	For purposes of determining the debt discount, the underlying assumptions used in the Black-Scholes model to determine the fair value of the 12% Warrants as of September 15, 2022, were: ​ ​ ​ ​ Current stock price $ 0.20 Exercise price ​ $ 0.70 Risk-free interest rate ​ ​ 3.66% Expected dividend yield ​ ​ — Expected term (in years) ​ ​ 5.0 Expected volatility ​ ​ 107% ​

WARRANT DERIVATIVE LIABILITY (T

WARRANT DERIVATIVE LIABILITY (Tables)	3 Months Ended
	Mar. 31, 2023
WARRANT DERIVATIVE LIABILITY.
Summary of key assumptions used to determine fair value of warrants	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ December 31, ​ ​ 2023 ​ 2022 Number of shares underlying the warrants ​ ​ 322,807 ​ ​ 322,807 ​ Fair market value of stock ​ $ 0.16 ​ $ 0.15 ​ Exercise price ​ $ 0.40 ​ $ 0.40 ​ Volatility ​ ​ 73 % 78 % Risk-free interest rate ​ ​ 4.64 % 3.99 % Warrant life (years) ​ ​ 1.16 ​ 1.41 ​ ​
Summary of the changes in the fair value of the warrant derivative liability	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ ​ 2023 2022 ​ Beginning balance ​ $ 5,508 ​ $ 28,317 ​ Warrant exercise ​ ​ — ​ ​ — ​ Change in fair value of warrants derivative liability ​ ​ (1,307) ​ ​ 60,664 ​ Ending balance ​ $ 4,201 ​ $ 88,981 ​

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	3 Months Ended
	Mar. 31, 2023
STOCKHOLDERS' EQUITY
Summary of Employee Awards activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted- ​ ​ ​ ​ ​ ​ ​ Weighted- ​ Average ​ ​ ​ ​ ​ ​ ​ Average ​ Remaining ​ ​ ​ ​ ​ Number of ​ Exercise Price ​ Contractual ​ Aggregate ​ Shares per Share Term (in years) Intrinsic Value Outstanding as of December 31, 2022 ​ 4,936,825 ​ $ 1.08 ​ 4.4 ​ $ 22,000 Granted ​ — ​ ​ — ​ ​ ​ Forfeited or expired — ​ — ​ Outstanding as of March 31, 2023 4,936,825 $ 1.08 4.4 ​ $ 22,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Exercisable as of March 31, 2023 4,776,945 ​ $ 1.11 4.4 ​ $ 4,000 ​

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2023
SEGMENT INFORMATION
Schedule of segment reporting information, by segment	Three months ended March 31, ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2023 Retail Cultivation Eliminations ​ Total Revenues ​ $ 5,110,619 ​ $ 684,017 ​ $ (684,017) ​ $ 5,110,619 Costs and expenses ​ ​ (4,535,568) ​ ​ (1,139,573) ​ ​ 684,017 ​ ​ (4,991,124) Segment operating income ​ $ 575,051 ​ $ (455,556) ​ $ — ​ ​ 119,495 Corporate expenses ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (1,920,293) Net loss from continuing operations before income taxes ​ ​ ​ ​ ​ ​ ​ ​ ​ $ (1,800,798) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2022 Retail Cultivation ​ Eliminations Total Revenues ​ $ 3,297,544 ​ $ 518,280 ​ $ (242,516) ​ $ 3,573,308 Costs and expenses ​ ​ (2,593,269) ​ ​ (707,549) ​ ​ 242,516 ​ ​ (3,058,302) Segment operating income ​ $ 704,275 ​ $ (189,269) ​ $ — ​ ​ 515,006 Corporate expenses ​ ​ ​ ​ ​ ​ ​ (1,381,345) Net loss from continuing operations before income taxes ​ ​ ​ ​ ​ ​ ​ ​ ​ $ (866,339) ​ ​ ​ ​
Summary of reconciliation of assets from segment to consolidated	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ December 31, Total assets 2023 2022 Retail ​ $ 25,691,073 ​ $ 25,212,245 Cultivation ​ ​ 4,925,079 ​ ​ 4,628,452 Corporate ​ 1,147,566 ​ 1,985,455 Total assets - segments ​ ​ 31,763,718 ​ ​ 31,826,152 Intercompany eliminations ​ ​ (336,354) ​ ​ (131,439) Total assets - consolidated ​ $ 31,427,364 ​ $ 31,694,713

NATURE OF OPERATIONS, HISTORY_3

NATURE OF OPERATIONS, HISTORY AND PRESENTATION (Details)			3 Months Ended
	Aug. 02, 2021 USD ($)	Jul. 16, 2021 USD ($)	Mar. 31, 2023 USD ($) item customer	Mar. 31, 2022 USD ($) customer	Dec. 31, 2022 USD ($)
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
Number of cannabis dispensaries the company operates | item			8
Number of cultivation facilities the company operates | item			5
Cash and cash equivalents			$ 1,460,162		$ 2,583,833
Net loss			(1,886,534)	$ (861,056)
Accumulated deficit			$ (95,288,616)		$ (93,384,382)
Colorado
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
Number of cannabis dispensaries the company operates | item			2
Oregon
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
Number of cannabis dispensaries the company operates | item			3
Next Big Crop [Member] | Discontinued Operations, Held-for-sale
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
Total of consideration		$ 150,000
Percentage of profits generated		10%
Period for percentage of profit		twelve months
Additional consideration	$ 75,000
Percentage of profit eliminated	10%
SevenFive Farm | Cultivation segment [Member] | Revenue Benchmark | Customer Concentration Risk
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
Concentration risk, percentage			88%	45%
Number of customers | customer			3	1
Green Trees Farm | Cultivation segment [Member] | Revenue Benchmark | Customer Concentration Risk
NATURE OF OPERATIONS, HISTORY AND PRESENTATION
Concentration risk, percentage			88%
Number of customers | customer			3

BUSINESS ACQUISITION - Summary

BUSINESS ACQUISITION - Summary (Details) - USD ($)			1 Months Ended
	Dec. 19, 2022	Dec. 12, 2022	Dec. 31, 2022
Trees MLK, Inc.
BUSINESS ACQUISITION
Discount Rate		12%
Fair Value		$ 3,017,510
Green Tree LLC
BUSINESS ACQUISITION
Cash paid for acquisition		$ 500,000
Stock issued in exchange for purchase of assets (in shares)		17,977,528
Share price on acquisition date (in dollars per share)		$ 0.165
Fair value of consideration transferred		$ 2,966,292
Consideration payable in equal monthly installments		$ 3,500,000	$ 3,500,000
Term of consideration payable in equal monthly installments		15 months	15 months
Green Man Corp
BUSINESS ACQUISITION
Cash paid for acquisition	$ 1,225,000
Stock issued in exchange for purchase of assets (in shares)	4,494,382
Share price on acquisition date (in dollars per share)	$ 0.18
Fair value of consideration transferred	$ 808,989
Consideration payable in equal monthly installments	$ 1,500,000		$ 1,500,000
Term of consideration payable in equal monthly installments	18 months		18 months
Discount Rate	12%
Fair Value	$ 1,224,846

BUSINESS ACQUISITION - Purchase

BUSINESS ACQUISITION - Purchase Price Allocation (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 19, 2022	Dec. 12, 2022
Preliminary purchase price allocation
Goodwill	$ 18,384,974	$ 18,384,974
Green Tree LLC
Preliminary purchase price allocation
Cash				$ 3,928
Inventory				1,588,454
Fixed assets				688,655
Tradename				950,000
Goodwill				3,255,679
Preliminary purchase price				$ 6,486,716
Green Man Corp
Preliminary purchase price allocation
Cash			$ 8,594
Inventory			108,543
Fixed assets			23,500
Tradename			150,000
Goodwill			2,968,198
Preliminary purchase price			$ 3,258,835

BUSINESS ACQUISITION - Pro Form

BUSINESS ACQUISITION - Pro Forma (Details)	3 Months Ended
	Mar. 31, 2022 USD ($) $ / shares shares
Green Tree LLC
Pro forma effects of the acquisition on the results of operations
Total revenues	$ 5,976,828
Net income (loss) attributable to common stockholders	$ (854,259)
Net income (loss) per common share | $ / shares	$ (0.01)
Weighted average number of basic and diluted common shares outstanding | shares	113,727,033
Green Man Corp
Pro forma effects of the acquisition on the results of operations
Total revenues	$ 5,010,218
Net income (loss) attributable to common stockholders	$ (950,487)
Net income (loss) per common share | $ / shares	$ (0.01)
Weighted average number of basic and diluted common shares outstanding | shares	100,243,887

ASSET ACQUISITION (Details)

ASSET ACQUISITION (Details) - USD ($)	1 Months Ended
	Feb. 28, 2023	Mar. 31, 2023	Dec. 31, 2022
Asset Acquisition [Line Items]
Intangible assets, net		$ 2,925,631	$ 2,543,898
Denver CO
Asset Acquisition [Line Items]
Cash paid for acquisition	$ 256,582
Consideration payable in equal monthly amounts	$ 385,873
Term of equal monthly payments	24 months
Intangible assets, net	$ 580,694

DISCONTINUED OPERATIONS (Detail

DISCONTINUED OPERATIONS (Details) - Discontinued Operations, Held-for-sale - Next Big Crop [Member] - USD ($)	Aug. 02, 2021	Jul. 16, 2021
DISCONTINUED OPERATIONS
Total of consideration		$ 150,000
Percentage of profits generated		10%
Period for percentage of profit		twelve months
Additional consideration	$ 75,000
Percentage of profit eliminated	10%

DISCONTINUED OPERATIONS - Summa

DISCONTINUED OPERATIONS - Summary of the Discontinued Operations (Details) - Operations Segment	3 Months Ended
	Mar. 31, 2022 USD ($)
DISCONTINUED OPERATIONS
Total revenues	$ 3,438
Selling, general and administrative	(1,845)
Total costs and expenses	(1,845)
Income (loss) from discontinued operations	5,283
Product revenues
DISCONTINUED OPERATIONS
Total revenues	$ 3,438

INVENTORIES, NET (Details)

INVENTORIES, NET (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
INVENTORIES, NET
Raw materials	$ 8,883	$ 8,883
Work-in-progress and finished goods	2,404,232	2,057,779
Inventories, net	$ 2,413,115	$ 2,066,662

LEASES (Details)

LEASES (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) lease	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) lease
OPERATING LEASE RIGHT-OF-USE ASSET / OPERATING LEASE LIABILITY
Increase Decrease In Operating Lease Liabilities		$ (277,574)
Right-of-use asset	$ 4,029,769		$ 3,866,406
Operating lease liability, current	843,431		1,433,184
Operating lease liability, non-current	3,314,127		$ 2,541,590
Lease liability	4,157,558
Rent expense	$ 596,091	$ 207,298
Number of operating leases | lease	1
Discount rate		20%
Finance lease
Finance lease liability	$ 749,505
Finance lease expense	50,000	$ 0
Related Party Leases
OPERATING LEASE RIGHT-OF-USE ASSET / OPERATING LEASE LIABILITY
Right-of-use asset	1,002,335
Operating lease liability, current	529,299
Operating lease liability, non-current	539,267
Rent expense	$ 127,790	$ 147,937
Number of related party operating leases | lease	3		3

LEASES - Schedule of Operating

LEASES - Schedule of Operating Lease Expense (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
LEASES
Straight-line operating lease expense	$ 393,265	$ 192,016
Variable lease cost	202,826	15,282
Total operating lease expense	$ 596,091	$ 207,298

LEASES - Future Remaining Minim

LEASES - Future Remaining Minimum Lease Payments (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Operating leases future remaining minimum lease payments
2023 (remaining nine months)	$ 1,184,542
2024	1,617,657
2025	1,309,970
2026	846,823
2027	507,871
Thereafter	965,354
Total	6,432,217
Less: Present value adjustment	(2,274,659)
Lease liability	4,157,558
Less: Lease liability, current	(843,431)	$ (1,433,184)
Lease liability, non-current	3,314,127	2,541,590
Finance leases future remaining minimum lease payments
2023 (remaining nine months)	150,000
2024	205,400
2025	171,043
2026	136,940
2027	143,102
Thereafter	818,100
Total	1,624,585
Less: Present value adjustment	(875,080)
Lease liability	749,505
Less: Lease liability, current	(60,008)	(55,777)
Lease liability, non-current	689,497	$ 706,653
Lease Renewal Options Exercise Remaining Minimum Lease Payments Due	$ 2,995,100
Operating Lease, Weighted Average Remaining Lease Term	4 years 6 months
Finance Lease, Weighted Average Remaining Lease Term	9 years 9 months

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
LEASES
Cash paid for amounts included in operating lease liability	$ 373,840	$ 170,276
Cash paid for amounts included in finance lease liability	50,000
ROU assets obtained in exchange for operating lease liabilities	$ 348,825	$ 172,053

ACCRUED STOCK PAYABLE (Details)

ACCRUED STOCK PAYABLE (Details) - USD ($)		1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 18, 2020	Dec. 31, 2021	Mar. 31, 2023	Dec. 31, 2022
Trees Waterfront LLC
ACCRUED STOCK PAYABLE
Number of shares granted		1,669,537
Common Stock awards
ACCRUED STOCK PAYABLE
Consultant stock award, Amount	$ 60,900
Consultant stock award, Shares	100,000
Stock price on date of grant (in dollars per share)	$ 0.61
Consultant stock award, shares issued				0
Common Stock awards | Common Stock
ACCRUED STOCK PAYABLE
Balance at beginning of the period, Amount			$ 60,900	$ 444,894
Balance at beginning of the period, Shares			100,000	1,769,537
Stock issued, Amount				$ (383,994)
Stock issued, Shares				(1,669,537)
Balance at end of the period, Amount		$ 444,894	$ 60,900	$ 60,900
Balance at end of the period, Shares		1,769,537	100,000	100,000

NOTES PAYABLE - Schedule of Not

NOTES PAYABLE - Schedule of Notes Payable (Details) - USD ($)	Mar. 31, 2023	Feb. 28, 2023	Dec. 31, 2022	Sep. 15, 2022
NOTES PAYABLE
Unamortized debt discount	$ (1,758,177)		$ (1,888,933)
Total debt	17,991,673		17,802,932
Less: Current portion	(1,879,173)		(1,903,344)
Long-term portion	16,112,500		15,899,588
12% Notes, 2022
NOTES PAYABLE
Debt carrying amount	13,500,000		13,500,000
Unamortized debt discount		$ (50,918)		$ (675,000)
12% Notes, 2023
NOTES PAYABLE
Debt carrying amount	384,873
Trees Acquisition Notes
NOTES PAYABLE
Debt carrying amount	864,977		1,191,865
Green Tree Acquisition Notes
NOTES PAYABLE
Debt carrying amount	3,500,000		3,500,000
Green Man Acquisition Notes
NOTES PAYABLE
Debt carrying amount	1,500,000		1,500,000
Third Party
NOTES PAYABLE
Unamortized debt discount	(1,399,890)		(1,527,346)
Total debt	14,042,656		13,915,200
Less: Current portion	(466,853)		(179,827)
Long-term portion	13,575,803		13,735,373
Third Party | 12% Notes, 2022
NOTES PAYABLE
Debt carrying amount	13,167,796		13,167,796
Third Party | Green Tree Acquisition Notes
NOTES PAYABLE
Debt carrying amount	774,750		774,750
Third Party | Green Man Acquisition Notes
NOTES PAYABLE
Debt carrying amount	1,500,000		1,500,000
Related Party
NOTES PAYABLE
Unamortized debt discount	(358,287)		(361,587)
Total debt	3,949,017		3,887,732
Less: Current portion	(1,412,320)		(1,723,517)
Long-term portion	2,536,697		2,164,215
Related Party | 12% Notes, 2022
NOTES PAYABLE
Debt carrying amount	332,204		332,204
Related Party | 12% Notes, 2023
NOTES PAYABLE
Debt carrying amount	384,873
Related Party | Trees Acquisition Notes
NOTES PAYABLE
Debt carrying amount	864,977		1,191,865
Related Party | Green Tree Acquisition Notes
NOTES PAYABLE
Debt carrying amount	$ 2,725,250		$ 2,725,250

NOTES PAYABLE - Trees Transacti

NOTES PAYABLE - Trees Transaction Notes (Details) - USD ($)			1 Months Ended		3 Months Ended
	Dec. 19, 2022	Dec. 12, 2022	Dec. 31, 2022	Jan. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Debt Instrument [Line Items]
Debt discount			$ 1,888,933		$ 1,758,177
TREES MLK
Debt Instrument [Line Items]
Consideration payable in equal monthly installments				$ 384,873
Term of consideration payable in equal monthly installments				24 months
Consideration payable in equal monthly amounts				$ 16,036
Green Man Corp
Debt Instrument [Line Items]
Consideration payable in equal monthly installments	$ 1,500,000		$ 1,500,000
Term of consideration payable in equal monthly installments	18 months		18 months
Consideration payable in equal monthly amounts			$ 83,333
Debt discount					275,154
Amortization of debt discount					37,250	$ 0
Green Tree LLC
Debt Instrument [Line Items]
Consideration payable in equal monthly installments		$ 3,500,000	$ 3,500,000
Term of consideration payable in equal monthly installments		15 months	15 months
Consideration payable in equal monthly amounts			$ 233,333
Debt discount					512,367
Amortization of debt discount					$ 61,016	$ 0

NOTES PAYABLE - 2020 12 Notes (

NOTES PAYABLE - 2020 12 Notes (Details) - USD ($)			1 Months Ended			3 Months Ended
	Sep. 15, 2022	Feb. 08, 2021	Feb. 28, 2023	Sep. 30, 2022	Dec. 31, 2020	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Apr. 20, 2021
Debt Instrument [Line Items]
Debt discount						$ 1,758,177		$ 1,888,933
Additional paid-in capital						$ 98,626,157		$ 98,598,761
10% Warrants
Debt Instrument [Line Items]
Interest rate (as a percent)	10%	10%			10%				10%
Percentage of aggregate principal amount coverage		20%			20%
Exercise price of warrants		$ 0.56			$ 0.56				$ 0.56
Additional paid-in capital									$ 810,000
12% Warrants
Debt Instrument [Line Items]
Interest rate (as a percent)	12%
Percentage of aggregate principal amount coverage	20%
Exercise price of warrants	$ 0.70
10% Notes
Debt Instrument [Line Items]
Interest rate (as a percent)	10%	10%		10%	10%	10%
Aggregate principal amount					$ 2,940,000
Aggregate indebtedness amount	$ 2,912,750
Stock issued					1,050,011
Amortization of debt discount				$ 1,125,844		$ 0	$ 21,393
12% Investors
Debt Instrument [Line Items]
Interest rate (as a percent)	12%
Proceeds from debt	$ 10,587,250
Percentage of aggregate principal amount coverage	50%
12% Investors | Maximum
Debt Instrument [Line Items]
Conversion price (in dollars per share)	$ 1
Twelve Percent Notes 2022 [Member]
Debt Instrument [Line Items]
Interest rate (as a percent)	12%		12%	12%		12%
Aggregate principal amount	$ 13,500,000
Stock issued	3,857,150
Debt fee percentage (as a percent)	5%
Debt discount	$ 675,000		$ 50,918
Amortization of debt discount			6,712			$ 76,699	$ 0
Consideration payable in equal monthly installments			$ 385,873
Term of consideration payable in equal monthly installments			24 months
Twelve Percent Notes 2022 [Member] | 12% Warrants
Debt Instrument [Line Items]
Stock issued	1,928,571
Debt discount | 10% Warrants
Debt Instrument [Line Items]
Additional paid-in capital		$ 429,300			$ 254,400
Debt discount | 12% Warrants
Debt Instrument [Line Items]
Additional paid-in capital	$ 569,223
Extinguishment of debt | 10% Warrants
Debt Instrument [Line Items]
Additional paid-in capital					$ 131,000
Extinguishment of debt | 12% Warrants
Debt Instrument [Line Items]
Additional paid-in capital	$ 103,577

NOTES PAYABLE - 2020 10 Notes (

NOTES PAYABLE - 2020 10 Notes (Details)			1 Months Ended			3 Months Ended
	Apr. 20, 2021 USD ($) item $ / shares	Feb. 08, 2021 USD ($) $ / shares shares	Feb. 28, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2020 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) $ / shares	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares	Sep. 15, 2022 USD ($) shares	Sep. 10, 2021 $ / shares
Debt Instrument [Line Items]
Additional paid-in capital						$ 98,626,157		$ 98,598,761
Common stock, par value (in dollars per share) | $ / shares						$ 0.001		$ 0.001		$ 0.001
Repayment of notes						$ 339,814	$ 258,057
10% Warrants
Debt Instrument [Line Items]
Interest rate (as a percent)	10%	10%			10%				10%
Percentage of aggregate principal amount coverage		20%			20%
Exercise price of warrants | $ / shares	$ 0.56	$ 0.56			$ 0.56
Additional paid-in capital	$ 810,000
10% Notes
Debt Instrument [Line Items]
Interest rate (as a percent)		10%		10%	10%	10%			10%
Aggregate principal amount					$ 2,940,000
Aggregate indebtedness amount									$ 2,912,750
Stock issued | shares					1,050,011
Amortization of debt discount				$ 1,125,844		$ 0	21,393
Beneficial conversion feature					$ 0
Debt exchanged amount				2,912,750
Repayment of notes				3,987,250
Debt extinguishment				$ 207,045
10% Notes 2021
Debt Instrument [Line Items]
Interest rate (as a percent)		10%
Aggregate principal amount		$ 1,660,000
Stock issued | shares		592,858
Conversion price (in dollars per share) | $ / shares		$ 0.66
Debt conversion commitment price (in dollars per share) | $ / shares		0.90
Amortization of debt discount						0	69,603
Common stock, par value (in dollars per share) | $ / shares		$ 0.001
10% Notes April 2021
Debt Instrument [Line Items]
Interest rate (as a percent)	10%
Aggregate principal amount	$ 2,300,000
Percentage of aggregate principal amount coverage	20%
Exercise price of warrants | $ / shares	$ 0.56
Conversion price (in dollars per share) | $ / shares	0.49
Debt conversion commitment price (in dollars per share) | $ / shares	$ 0.83
Amortization of debt discount						$ 0	123,285
Convertible note offering amount	$ 4,600,000
Number of lead investor | item	1
Aggregate principal amount invested	35.50%
10% Investors
Debt Instrument [Line Items]
Interest rate (as a percent)	10%	10%			10%
Proceeds from debt					$ 1,940,000
Conversion price trigger (as a percent)	80%	80%			80%
10% Investors | Minimum
Debt Instrument [Line Items]
Conversion price (in dollars per share) | $ / shares	$ 0.65	$ 0.65			$ 0.65
10% Investors | Maximum
Debt Instrument [Line Items]
Percentage of aggregate principal amount coverage	50%	50%			50%
Conversion price (in dollars per share) | $ / shares	$ 1	$ 1			$ 1
Twelve Percent Notes 2022 [Member]
Debt Instrument [Line Items]
Interest rate (as a percent)			12%	12%		12%			12%
Aggregate principal amount									$ 13,500,000
Stock issued | shares									3,857,150
Amortization of debt discount			$ 6,712			$ 76,699	$ 0
15% Notes
Debt Instrument [Line Items]
Interest rate (as a percent)					15%
Aggregate indebtedness amount					$ 1,000,000
Debt discount | 10% Warrants
Debt Instrument [Line Items]
Additional paid-in capital		$ 429,300			254,400
Debt discount | 10% Notes 2021
Debt Instrument [Line Items]
Additional paid-in capital		$ 417,539
Debt discount | 10% Notes April 2021
Debt Instrument [Line Items]
Additional paid-in capital	$ 692,500
Extinguishment of debt | 10% Warrants
Debt Instrument [Line Items]
Additional paid-in capital					$ 131,000

NOTES PAYABLE - Assumptions Use

NOTES PAYABLE - Assumptions Used to Calculate Fair Value of Warrants (Details)	Sep. 15, 2022 $ / shares USD ($) Y	Apr. 20, 2021 Y $ / shares USD ($)	Feb. 08, 2021 $ / shares Y	Dec. 23, 2020 $ / shares Y
10% Warrants | Current stock price
NOTES PAYABLE
Measurement input used to calculate fair value of warrants | $ / shares		0.83	1.12	0.53
10% Warrants | Exercise price
NOTES PAYABLE
Measurement input used to calculate fair value of warrants		0.56	0.56	0.56
10% Warrants | Risk-free interest rate
NOTES PAYABLE
Measurement input used to calculate fair value of warrants		0.81	0.48	0.38
10% Warrants | Expected term (in years)
NOTES PAYABLE
Measurement input used to calculate fair value of warrants | Y		5	5	5
10% Warrants | Expected volatility
NOTES PAYABLE
Measurement input used to calculate fair value of warrants		115	118	115
12% Warrants | Current stock price
NOTES PAYABLE
Measurement input used to calculate fair value of warrants | $ / shares	0.20
12% Warrants | Exercise price
NOTES PAYABLE
Measurement input used to calculate fair value of warrants | $	0.70
12% Warrants | Risk-free interest rate
NOTES PAYABLE
Measurement input used to calculate fair value of warrants	3.66
12% Warrants | Expected term (in years)
NOTES PAYABLE
Measurement input used to calculate fair value of warrants | Y	5
12% Warrants | Expected volatility
NOTES PAYABLE
Measurement input used to calculate fair value of warrants	107

WARRANT DERIVATIVE LIABILITY -

WARRANT DERIVATIVE LIABILITY - Summary (Details) - USD ($)		1 Months Ended	3 Months Ended				12 Months Ended
	May 31, 2019	May 31, 2020	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2022
WARRANT DERIVATIVE LIABILITY
Common stock, shares issued			118,664,094					118,664,094
Gain (loss) on warrant derivative liability			$ 1,307	$ (60,664)
2019 Warrants [Member}
WARRANT DERIVATIVE LIABILITY
Proceeds from issuance of common stock and warrants	$ 3,000,000
Shares issued in cashless exercise of warrants					747,208
Common stock, shares issued	3,000,000
Number of warrants issued	3,000,000
Share price	$ 1
Exercise price of warrants	$ 1.30
Warrant exercise price, decrease (in dollars per share)		$ 0.45				$ 0.45	$ 0.3983
Common stock, other shares, outstanding			322,807			8,666,666	9,591,614
Warrants exercised					1,323,000
Adjustment to derivative liability					$ 1,523,117
Gain (loss) on warrant derivative liability			$ 1,307	$ (60,664)

WARRANT DERIVATIVE LIABILITY _2

WARRANT DERIVATIVE LIABILITY - Assumptions Used to Calculate Fair Value of 2019 Warrants (Details) - 2019 Warrants [Member}	Mar. 31, 2023 $ / shares	Mar. 31, 2023	Mar. 31, 2023 Y	Mar. 31, 2023 item	Dec. 31, 2022 $ / shares	Dec. 31, 2022	Dec. 31, 2022 Y	Dec. 31, 2022 item
Number of shares underlying the warrants
WARRANT DERIVATIVE LIABILITY
Measurement input used to calculate fair value of warrants		0.16		322,807		0.15		322,807
Current stock price
WARRANT DERIVATIVE LIABILITY
Measurement input used to calculate fair value of warrants | $ / shares	0.40				0.40
Exercise price
WARRANT DERIVATIVE LIABILITY
Measurement input used to calculate fair value of warrants		0.73				0.78
Expected volatility
WARRANT DERIVATIVE LIABILITY
Measurement input used to calculate fair value of warrants		0.0464				0.0399
Risk-free interest rate
WARRANT DERIVATIVE LIABILITY
Measurement input used to calculate fair value of warrants | Y			0.0116				0.0141

WARRANT DERIVATIVE LIABILITY _3

WARRANT DERIVATIVE LIABILITY - Schedule of Level 3 Financial Liabilities (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Changes in the fair value of the warrant derivative liability
Beginning balance	$ 5,508	$ 28,317
Change in fair value of warrants derivative liability	(1,307)	60,664
Ending balance	$ 4,201	$ 88,981

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)		3 Months Ended		12 Months Ended
	Nov. 01, 2020	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
Cash paid for amounts included in operating lease liability		$ 373,840	$ 170,276
2353 SB, LLC
COMMITMENTS AND CONTINGENCIES
Lease agreement terms	3 years
Monthly lease payments	$ 12,867
Cash paid for amounts included in operating lease liability				$ 39,633

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - USD ($)	Sep. 14, 2021	Sep. 10, 2021	Mar. 31, 2023	Dec. 31, 2022
STOCKHOLDERS' EQUITY
Common stock, par value (in dollars per share)		$ 0.001	$ 0.001	$ 0.001
Preferred stock, par value (in dollars per share)			$ 0	$ 0
Preferred stock, shares authorized			5,000,000	5,000,000
Accrued dividends			$ 106,200	$ 88,500
Series A Preferred
STOCKHOLDERS' EQUITY
Preferred shares issued		$ 1,180,000
Preferred shares issued (in shares)		1,180
Purchase price per unit		$ 1,000
Number of units issued		1,180
Aggregate amount sold		$ 1,180,000
Number of common stock issuable for each preferred share	1,000	1,000
Number of preferred shares per unit		1
Minimum capital raise	$ 5,000,000	$ 5,000,000
Preferred stock, par value (in dollars per share)	$ 0
Preferred stock, shares authorized	5,000
Preferred stock, voting rights	None
Preferred stock, dividend (percentage)	6%
Preferred Warrants
STOCKHOLDERS' EQUITY
Exercise price of warrants	$ 1.05
Term of warrants	5 years
Number of warrants per unit		354,000
Threshold per share price during future capital raise	$ 1
Preferred Warrants | Series A Preferred
STOCKHOLDERS' EQUITY
Number of warrants per unit		354,000
Warrants fair value		$ 117,131
Amount of warrants allocated to preferred stock		$ 1,073,446

STOCKHOLDERS' EQUITY - Share-Ba

STOCKHOLDERS' EQUITY - Share-Based Compensation (Details)		3 Months Ended		12 Months Ended
	Apr. 01, 2022 USD ($) item tranche $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares
Share-based compensation
Stock-based compensation (income)/expense | $		$ 27,396	$ 76,117
Granted				250,000
Stock-based compensation options, expiration period		5 years
Vesting period		1 year
Fair value of awards, grant date | $		$ 56,348
Unrecognized compensation expense related to unvested Employee Awards | $		$ 722
Recognition period related to unvested Employee Awards		14 months
Number of Shares
Outstanding, beginning of period		4,936,825
Granted				250,000
Outstanding, end of period		4,936,825		4,936,825
Exercisable, end of period		4,776,945
Weighted-average Exercise Price per Share
Outstanding, beginning of period | $ / shares		$ 1.08
Outstanding, end of period | $ / shares		1.08		$ 1.08
Exercisable, end of period | $ / shares		$ 1.11
Weighted-average Remaining Contractual Term (in years)
Outstanding contractual term (in years)		4 years 4 months 24 days		4 years 4 months 24 days
Exercisable, end of period		4 years 4 months 24 days
Aggregate Intrinsic Value
Outstanding, end of period | $		$ 22,000		$ 22,000
Exercisable, end of period | $		4,000
2020 Plan
Share-based compensation
Stock-based compensation expense | $		$ 13,894	$ 0
Fair value instruments | $	$ 535,976
Requisite service period derived from the valuation period	10 years
Restricted Stock Units (RSUs) | 2020 Plan
Share-based compensation
Number of participants in restricted stock unit agreement | item	4
Number of executives to whom restricted stock units granted | item	4
Number of tranches | tranche	3
Vested		0
Restricted Stock Units (RSUs) | 2020 Plan | Tranche 1
Share-based compensation
Shares granted	100,000
Share Price | $ / shares	$ 1
Restricted Stock Units (RSUs) | 2020 Plan | Tranche 2
Share-based compensation
Shares granted	100,000
Share Price | $ / shares	$ 2
Restricted Stock Units (RSUs) | 2020 Plan | Tranche 3
Share-based compensation
Shares granted	100,000
Share Price | $ / shares	$ 3
Restricted Stock Units (RSUs) | 2020 Plan | Executive Officer
Share-based compensation
Shares granted	1,200,000
Restricted Stock Units (RSUs) | 2020 Plan | Executive One
Share-based compensation
Shares granted	300,000
Restricted Stock Units (RSUs) | 2020 Plan | Executive Two
Share-based compensation
Shares granted	300,000
Restricted Stock Units (RSUs) | 2020 Plan | Executive Three
Share-based compensation
Shares granted	300,000
Restricted Stock Units (RSUs) | 2020 Plan | Executive Four
Share-based compensation
Shares granted	300,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details)		1 Months Ended	3 Months Ended
	Sep. 16, 2022 USD ($) shares	Jan. 31, 2023 USD ($)	Mar. 31, 2023 USD ($) ft²	Mar. 31, 2022 USD ($)	Feb. 28, 2023	Dec. 31, 2022 USD ($)	Sep. 30, 2022	Sep. 15, 2022 shares	Feb. 08, 2021	Dec. 31, 2020 shares
RELATED PARTY TRANSACTIONS
Aggregate rent expense			$ 373,840	$ 170,276
10% Notes
RELATED PARTY TRANSACTIONS
Number of warrants issued | shares										1,050,011
Interest rate (as a percent)			10%				10%	10%	10%	10%
Twelve Percent Notes 2022 [Member]
RELATED PARTY TRANSACTIONS
Number of warrants issued | shares								3,857,150
Aggregate amount			$ 13,500,000			$ 13,500,000
Interest rate (as a percent)			12%		12%		12%	12%
Consulting agreement | Board of Directors Chairman
RELATED PARTY TRANSACTIONS
Chief executive officer with compensation	$ 200,000
Renewal term of consulting agreement	6 months
Term of consulting agreement	1 year
Number of warrants issued | shares	7,280,007
Aggregate amount of consulting fees paid			$ 50,000	24,999
Additional term	2 years
Lease agreement | Dalton Adventures, LLC
RELATED PARTY TRANSACTIONS
Leased space (in sq ft) | ft²			17,000
Monthly rent expenses			$ 29,691
Monthly rent attributable to base rent		$ 27,405	27,000
Monthly rent attributable to property taxes			2,691
Aggregate rent expense			75,848	112,325
Lease agreement | Bellewood Holdings, LLC
RELATED PARTY TRANSACTIONS
Monthly rent expenses			11,287
Monthly rent attributable to base rent			10,000
Monthly rent attributable to property taxes			1,287
Aggregate rent expense			0	35,612
Lease agreement | JLA Enterprises, LLC
RELATED PARTY TRANSACTIONS
Aggregate rent expense			$ 51,942	$ 0

SEGMENT INFORMATION - Net Loss

SEGMENT INFORMATION - Net Loss by Segment (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 USD ($)
Segment Reporting Information
Number of operating segments | segment	2
Total revenue	$ 5,110,619	$ 3,573,308
Continuing Operations
Segment Reporting Information
Total revenue	5,110,619	3,573,308
Costs and expenses	(4,991,124)	(3,058,302)
Segment operating income (loss)	119,495	515,006
Corporate expenses	(1,920,293)	(1,381,345)
Net loss from continuing operations before income taxes	(1,800,798)	(866,339)
Operating segments | Retail
Segment Reporting Information
Total revenue	5,110,619	3,297,544
Costs and expenses	(4,535,568)	(2,593,269)
Segment operating income (loss)	575,051	704,275
Operating segments | Cultivation
Segment Reporting Information
Total revenue	684,017	518,280
Costs and expenses	(1,139,573)	(707,549)
Segment operating income (loss)	(455,556)	(189,269)
Eliminations
Segment Reporting Information
Total revenue	(684,017)	(242,516)
Costs and expenses	$ 684,017	$ 242,516

SEGMENT INFORMATION - Total Ass

SEGMENT INFORMATION - Total Assets by Segment (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
SEGMENT INFORMATION
Total assets	$ 31,427,364	$ 31,694,713
Operating segments
SEGMENT INFORMATION
Total assets	31,763,718	31,826,152
Operating segments | Retail
SEGMENT INFORMATION
Total assets	25,691,073	25,212,245
Operating segments | Cultivation
SEGMENT INFORMATION
Total assets	4,925,079	4,628,452
Operating segments | Corporate
SEGMENT INFORMATION
Total assets	1,147,566	1,985,455
Eliminations
SEGMENT INFORMATION
Total assets	$ (336,354)	$ (131,439)

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - shares		3 Months Ended
	Apr. 01, 2023	Mar. 31, 2023
Subsequent Event [Line Items]
Vesting period		1 year
Subsequent Event | Restricted Stock Units (RSUs)
Subsequent Event [Line Items]
Shares granted	201,250
Vesting period	7 years
Number of shares to be issued upon vesting of each award	1